CoChat

Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome

Open access
Tandon, Rajiv, Mazzara, Cheryl, DeQuardo, John, Craig, Katherine A., Meador-Woodruff, James H., Goldman, Robert, Greden, John F. · 1991 · Biological Psychiatry

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Abstract

To relieve confusion about the clinical correlates and prognostic implications of the dexamethasone suppression test (DST) in schizophrenia, we conducted a DST in 44 schizophrenic inpatients at drug-free baseline and approximately 4 weeks after neuroleptic treatment. Patients were rated on positive, negative, and depressive symptoms at both times. A head computed tomography (CT) scan was performed and measures of ventricle-brain ratio (VBR) obtained. Clinical improvement was monitored at four weeks, and longer-term outcome assessed at 1 year. Seventeen of the 44 patients were DST nonsuppressors at baseline, and five of these remained nonsuppressors at 4 weeks posttreatment. Postdexamethasone plasma cortisol levels were correlated with negative symptoms at baseline (r = 0.45; p less than 0.01), but not after 4 weeks of neuroleptic treatment. Postdexamethasone plasma cortisols were not related to global severity, positive, or depressive symptoms at either timepoint or to VBR. Persistent nonsuppression was associated with poor outcome, but baseline postdexamethasone cortisol levels were unrelated to outcome at 4 weeks and 1 year. The literature on DST in schizophrenia is reviewed and attempts are made to reconcile discrepant findings and to discuss pathophysiological implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0006-3223(91)90353-n

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Research works printed but not linked: 4

  1. Andreasen NC (1983): Scale for the Assessment of Negative Symptoms (SANS). !own City, Iowa, University of Iowa Press.
  2. Hedluad JL, Vieweg BW (1980): The Brief Psychiatric Rating Scale (BPRS): A comprehensive review. J Operational Psychiatry 11:48-65.
  3. Nisbimon K, Sora l, Sato M, Otsuki S (1984): Clinical relevance of dexamethasone suppression test (DST) in affective and schizophrenic disorders. Annu Rev Pharmacopsychiatry Res Found 15:256-262.
  4. Rihmer Z, Arato M (1984): The DST as a clinical aid and rese~_rch tc-~t in patients with affective disorder. Psychopharmacol Buil 20:174-t77.

Cited by

See all 168

Metadata

Authors
Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F.
Affiliations
University of Michigan (US)
Corresponding author
Tandon, Rajiv
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
1991-05
Volume
29
Issue
10
Pages
953-964
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2077436874
Cited by
168
References
78
Citations by year
2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 5 · 2013: 2 · 2012: 6
FWCI
4.53
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
National Center for Research Resources (M-01RR00042, M01RR000042)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
dexamethasone suppression test, schizophrenia, negative symptoms, ventriculomegaly, ventricle-brain ratio, antipsychotic drugs, plasma cortisol, prognostic outcome, hypothalamic-pituitary-adrenal axis, depressive symptoms, positive symptoms
MeSH terms
Adolescent, Adult, Cerebral Ventricles, Dexamethasone, Female, Humans, Hydrocortisone, Male, Middle Aged, Prognosis, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology, Tomography, X-Ray Computed, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome. https://app.cochat.ai/papers/10.1016/0006-3223(91)90353-n
The paper
Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991). Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome. Biological Psychiatry. https://doi.org/10.1016/0006-3223(91)90353-n

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.